OptiNose, Inc. Contracts & Agreements

Consulting Agreement, dated June 8, 2023, between OptiNose (Filed With SEC on June 13, 2023)

Amended and Restated Employment Agreement, dated May (Filed With SEC on May 11, 2023)

Amended and Restated Employment Agreement, dated Ma (Filed With SEC on May 11, 2023)

Description of Securities of OptiNose, Inc (Filed With SEC on March 7, 2023)

Form of Indemnification Agreement (Filed With SEC on March 7, 2023)

Amended and Restated Employment Agreement, dated January 30, 2023, between OptiNose US, Inc. and Ramy A. Mahmoud (Filed With SEC on January 31, 2023)

Form of Separation Agreement and General Release (Filed With SEC on January 31, 2023)

Consulting Agreement, dated January 3 (Filed With SEC on January 31, 2023)

Consulting Agreement, dated December 16, 2022, between OptiNose US, Inc. and (Filed With SEC on December 16, 2022)

Employment Agreement, dated December 15, 2022, between OptiNose US, Inc. and Paul Spence, Jr (Filed With SEC on December 15, 2022)

Underwriting Agreement, dated November 21, 2022, by and between OptiNose, Inc. and Piper Sandler & Co (Filed With SEC on November 23, 2022)

Form of Warrant (Filed With SEC on November 23, 2022)

Warrant Agency Agreement, dated November 23, 2022, by and between OptiNose, Inc. and Broadridge Corporate Issuer Solutions, Inc (Filed With SEC on November 23, 2022)

Form of Indemnification Agreement (Filed With SEC on November 10, 2022)

Third Amendment, dated August 10, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS,... (Filed With SEC on November 10, 2022)

Fourth Amendment, dated November 9, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose Inc., OptiNose UK Limited and OptiNose AS,... (Filed With SEC on November 10, 2022)

Form of Indemnification Agreement (Filed With SEC on August 11, 2022)

Third Amendment, dated August 10, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS,... (Filed With SEC on August 11, 2022)

Cooperation Agreement, dated April 25, 2022, by and among OptiNose, Inc. M. Kingdon Offshore Master Fund L.P., Velan Capital Partners LP and certain other affiliated investors... (Filed With SEC on May 12, 2022)

Form of Indemnification Agreement (Filed With SEC on May 12, 2022)

Cooperation Agreement, dated April 25, 2022, by and among OptiNose, Inc. M. Kingdon Offshore Master Fund L.P., Velan Capital Partners LP and certain other affiliated investors... (Filed With SEC on April 26, 2022)

Form of Indemnification Agreement (Filed With SEC on March 8, 2022)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2022)

Amended and Restated Employment Agreement, dated March 2, 2022, between OptiNose US, Inc. and Peter K. Miller (Filed With SEC on March 8, 2022)

Retention Agreement, dated March 7, 2022, between Michael F. Marino and Optinose US, Inc (Filed With SEC on March 8, 2022)

Underwriting Agreement, dated November 16, 2021, by and between OptiNose, Inc. and Piper Sandler & Co (Filed With SEC on November 18, 2021)

Form of New Warrant (Filed With SEC on November 16, 2021)

Second Amendment to the Note Purchase Agreement, dated November 16, 2021, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as... (Filed With SEC on November 16, 2021)

Open Market Sale Agreement (the Sale Agreement), dated August 11, 2021, between the Company and Jefferies LLC (Filed With SEC on November 15, 2021)

Open Market Sale Agreement (the Sale Agreement), dated August 11, 2021, between the Company and Jefferies LLC (Filed With SEC on August 11, 2021)

Renewal and Amendment No. 1, dated February 22, 2021 to Manufacture and Supply Agreement, dated as of August 18, 2017, by and among OptiNose US, Inc., OptiNose UK Ltd. and... (Filed With SEC on May 5, 2021)

Form of Indemnification Agreement (Filed With SEC on March 3, 2021)

First Amendment to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as... (Filed With SEC on March 3, 2021)

Amendment No.1, dated September 15, 2020, to the Manufacturing Services Agreement, dated December 21, 2018, by and among OptiNose US, Inc., OptiNose UK Ltd. and Optinose AS and... (Filed With SEC on November 5, 2020)

Underwriting Agreement, dated August 13, 2020, by and between Opti (Filed With SEC on August 18, 2020)

Amendment Letter to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as... (Filed With SEC on August 18, 2020)

Form of Restricted Stock Unit Agreement (Inducement Grant) (Filed With SEC on May 7, 2020)

Note dated April 6, 2020, between OptiNose US, Inc. and JPMorgan Chase Bank, N.A (Filed With SEC on April 16, 2020)

Description of Securities of OptiNose, Inc (Filed With SEC on March 5, 2020)

Form of Indemnification Agreement (Filed With SEC on March 5, 2020)

Underwriting Agreement, dated November 20, 2019, by and between OptiNose, Inc., Jefferies LLC, Cowen and Company, LLC, Piper Jaffray & Co. and the Selling Stockholders named... (Filed With SEC on November 21, 2019)

Common Stock Warrant issued by Optinose, Inc. dated September 12, 2019 (Filed With SEC on September 12, 2019)

Form of Restricted Stock Unit Agreement Under the 2010 Stock Incentive Plan (Filed With SEC on August 12, 2019)

Form of Indemnification Agreement (Filed With SEC on March 6, 2019)

Manufacturing Services Agreement, dated December 21, 2018, by and among OptiNose US, Inc., OptiNose UK Ltd. and Optinose AS and Advance Mold & Manufacturing, Inc. d/b/a Vision... (Filed With SEC on March 6, 2019)

Form of Indemnification Agreement (Filed With SEC on August 14, 2018)

Form of Underwriting Agreement (Filed With SEC on June 4, 2018)

Form of Indemnification Agreement (Filed With SEC on March 13, 2018)

Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Peter K. Miller (Filed With SEC on October 18, 2017)

Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Ramy A. Mahmoud (Filed With SEC on October 18, 2017)

Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Thomas E. Gibbs (Filed With SEC on October 18, 2017)

Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Keith A. Goldan (Filed With SEC on October 18, 2017)

Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Michael F. Marino (Filed With SEC on October 18, 2017)

Form of Underwriting Agreement (Filed With SEC on October 11, 2017)

First Amendment to the Second Amended and Restated Shareholders Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders (Filed With SEC on October 11, 2017)

First Amendment to the Second Amended and Restated Registration Rights Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders (Filed With SEC on October 11, 2017)

Form of Indemnification Agreement (Filed With SEC on October 11, 2017)

Employment Agreement between OptiNose US, Inc. and Peter K. Miller to be in effect upon the closing of this offering (Filed With SEC on October 11, 2017)

Employment Agreement between OptiNose US, Inc. and Ramy A. Mahmoud to be in effect upon the closing of this offering (Filed With SEC on October 11, 2017)

Employment Agreement between OptiNose US, Inc. and Thomas E. Gibbs to be in effect upon the closing of this offering (Filed With SEC on October 11, 2017)

Employment Agreement between OptiNose US, Inc. and Keith A. Goldan to be in effect upon the closing of this offering (Filed With SEC on October 11, 2017)

Employment Agreement between OptiNose US, Inc. and Michael F. Marino to be in effect upon the closing of this offering (Filed With SEC on October 11, 2017)

Amended and Restated 2010 Stock Incentive Plan (Filed With SEC on October 11, 2017)

2017 Employee Stock Purchase Plan (Filed With SEC on October 11, 2017)

First Amendment to the Second Amended and Restated Shareholders Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders (Filed With SEC on October 3, 2017)

Stockholders' Agreement, dated October 2, 2017, by and among OptiNose, Inc. and certain of its stockholders (Filed With SEC on October 3, 2017)

First Amendment to the Second Amended and Restated Registration Rights Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders (Filed With SEC on October 3, 2017)

Form of Indemnification Agreement (Filed With SEC on October 3, 2017)

Amended and Restated 2010 Stock Incentive Plan (Filed With SEC on October 3, 2017)

Form of Non-Qualified Stock Option Agreement Granted Under the 2010 Stock Incentive Plan (Relating to Success Pool Grants) (Filed With SEC on October 3, 2017)

Form of Non-Qualified Stock Option Agreement Granted Under the 2010 Stock Incentive Plan (Relating to Option Pool Grants) (Filed With SEC on October 3, 2017)

Form of Non-Qualified Stock Option Agreement Granted Under the 2010 Stock Incentive Plan (Filed With SEC on October 3, 2017)

Form of Non-Qualified Stock Option Agreement to be Granted Under the Amended and Restated 2010 Stock Incentive Plan (Filed With SEC on October 3, 2017)

2017 Employee Stock Purchase Plan (Filed With SEC on October 3, 2017)

Exchange Agreement, dated as of June 7, 2010, by and among the Registrant, OptiNose AS and the other signatories thereto (the Registrant hereby agrees to furnish supplementally a... (Filed With SEC on September 18, 2017)

Second Amended and Restated Registration Rights Agreement, dated March 24, 2017, by and among the Registrant and certain of its stockholders (Filed With SEC on September 18, 2017)

Second Amended and Restated Shareholders' Agreement, dated March 24, 2017, by and among the Registrant and certain of its stockholders (Filed With SEC on September 18, 2017)

Form of Warrant issued by the Registrant on June 7, 2010 (Filed With SEC on September 18, 2017)

Employment Agreement, dated as of May 27, 2010, by and between the Registrant and Peter K. Miller (Filed With SEC on September 18, 2017)

Letter Agreement, dated as of June 18, 2010, by and between the Registrant and Ramy A. Mahmoud (Filed With SEC on September 18, 2017)

Letter Agreement, dated as of September 15, 2016, by and between OptiNose US, Inc. and Thomas E. Gibbs (Filed With SEC on September 18, 2017)

Letter Agreement, dated as of January 13, 2017, by and between OptiNose US, Inc. and Keith A. Goldan (Filed With SEC on September 18, 2017)

Letter Agreement, dated as of January 13, 2017, by and between OptiNose US, Inc. and Michael F. Marino (Filed With SEC on September 18, 2017)

License Agreement, dated as of July 1, 2013, by and between OptiNose AS and Avanir Pharmaceuticals, Inc (Filed With SEC on September 18, 2017)

First Amendment of License Agreement, dated as of April 25, 2014, by and between OptiNose US, Inc. and Avanir Pharmaceuticals, Inc (Filed With SEC on September 18, 2017)

Amendment to License Agreement, dated as of August 6, 2015, by and between OptiNose AS and Avanir Pharmaceuticals, Inc (Filed With SEC on September 18, 2017)

Supply Agreement, dated July 1, 2017, by and between Hovione Inter Ltd and OptiNose US, Inc., OptiNose UK, Ltd and OptiNose AS (Filed With SEC on September 18, 2017)

Manufacture and Supply Agreement, dated as of August 18, 2017, by and among OptiNose US, Inc., OptiNose UK Ltd. and OptiNose AS and Contract Pharmaceuticals Limited Canada (Filed With SEC on September 18, 2017)

Manufacturing Services Agreement, dated as of August 31, 2017, by and among OptiNose US, Inc., OptiNose UK Ltd. and OptiNose AS and Ximedica, LLC (Filed With SEC on September 18, 2017)